The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI

Among type 2 diabetic patients with AMI undergoing PCI, TMZ significantly reduces serum myocardial enzyme, improves liver function, adjusts blood glucose and improves cardiac function.